rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Catherine M. Engelbert

Director

Company insider

Files Form 4 as: Director, Royalty Pharma; Director, McDonald's.

In numbers

Trades disclosed
20
Buys
3
Sells
0
Bought
$447K
Sold
$0
Companies
2
Companies where not an officer
2
First trade
31 Dec 2019
Last trade
5 Jun 2026
Last filed
8 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
RPRX Royalty PharmaDirector · Pharmaceuticals · last 5 Jun 20260 buys · 0 sells
MCD McDonald'sDirector · Restaurants · last 31 Dec 20253 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Jun 2026filed 8 Jun 2026RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—4,545 at $0.00filing
5 Jun 2026filed 8 Jun 2026RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—4,545 at $0.00filing
31 Dec 2025filed 5 Jan 2026MCD McDonald'soption or derivative · RestaurantsSEC FORM 4 Code A$205K670.75 at $305.63filing
31 Dec 2025filed 5 Jan 2026MCD McDonald'soption or derivative · RestaurantsSEC FORM 4 Code A$205K670.75 at $305.63filing
13 May 2025filed 15 May 2025RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—7,614 at $0.00filing
31 Dec 2024filed 3 Jan 2025MCD McDonald'soption or derivative · RestaurantsSEC FORM 4 Code A$203K700.47 at $289.89filing
7 Jun 2024filed 10 Jun 2024RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—9,293 at $0.00filing
31 Dec 2023filed 3 Jan 2024MCD McDonald'soption or derivative · RestaurantsSEC FORM 4 Code A$200K674.51 at $296.51filing
23 Jun 2023filed 26 Jun 2023RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—7,747 at $0.00filing
3 Apr 2023filed 4 Aug 2023MCD McDonald'sRestaurantsSEC FORM 4 Bought$11K38 at $281.03filing
31 Dec 2022filed 4 Jan 2023MCD McDonald'soption or derivative · RestaurantsSEC FORM 4 Code A$191K726.49 at $263.53filing
24 Jun 2022filed 24 Jun 2022RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—6,328 at $0.00filing
28 Feb 2022filed 2 Mar 2022MCD McDonald'sRestaurantsSEC FORM 4 Bought$244K1,000 at $244.18filing
31 Dec 2021filed 4 Jan 2022MCD McDonald'soption or derivative · RestaurantsSEC FORM 4 Code A$185K690.12 at $268.07filing
25 Jun 2021filed 29 Jun 2021RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—5,726 at $0.00filing
31 Dec 2020filed 5 Jan 2021MCD McDonald'soption or derivative · RestaurantsSEC FORM 4 Code A$185K862.15 at $214.58filing
30 Sep 2020filed 2 Oct 2020RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A$37K910 at $41.17filing
18 Jun 2020filed 23 Sep 2020RPRX Royalty PharmaPharmaceuticalsSEC FORM 4 Code A—12,500 at $0.00filing
28 Feb 2020filed 3 Mar 2020MCD McDonald'sRestaurantsSEC FORM 4 Bought$192K1,000 at $192.13filing
31 Dec 2019filed 3 Jan 2020MCD McDonald'soption or derivative · RestaurantsSEC FORM 4 Code A$13K66.69 at $197.61filing

Sectors

Consumer Discretionary3

Buys in green, sells in red, by the company’s sector.

Related people

Marshall UristEVP, Research & Investments · EVP, Research & Investments at Royalty Pharma, filing Form 4 there in the last year
Michael D. HsuDirector · Director at Mcdonalds, filing Form 4 there in the last year
Lloyd H. DeanDirector · Director at Mcdonalds, filing Form 4 there in the last year
Jennifer L. TaubertDirector · Director at Mcdonalds, filing Form 4 there in the last year
Bonnie L. BasslerDirector · Director at Royalty Pharma, filing Form 4 there in the last year
Josh GottheimerRepresentative, NJ-05 · Also traded MCD in the last 90 days
Scott FranklinRepresentative, FL-18 · Also traded MCD in the last 90 days
Donald J. TrumpPresident · Also traded MCD in the last 90 days